Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Humoral Response after SARS-CoV-2 mRNA Vaccination in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients
Clément Danthu, Sébastien Hantz, Arthur Dahlem, et al.
Journal of the American Society of Nephrology (2021) Vol. 32, Iss. 9, pp. 2153-2158
Open Access | Times Cited: 160

Showing 1-25 of 160 citing articles:

Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
Ainsley Ryan Yan Bin Lee, Shi Yin Wong, Louis Yi Ann Chai, et al.
BMJ (2022), pp. e068632-e068632
Open Access | Times Cited: 390
Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review
Simon Galmiche, Liêm Binh Luong Nguyen, Éric Tartour, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 2, pp. 163-177
Open Access | Times Cited: 175
Assessing Acceptability of COVID-19 Vaccine Booster Dose among Adult Americans: A Cross-Sectional Study
Tesfaye Yadete, Kavita Batra, Dale Netski, et al.
Vaccines (2021) Vol. 9, Iss. 12, pp. 1424-1424
Open Access | Times Cited: 133
COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety
Nicoletta Luxi, Alexia Giovanazzi, Annalisa Capuano, et al.
Drug Safety (2021) Vol. 44, Iss. 12, pp. 1247-1269
Open Access | Times Cited: 124
Effects of age, sex, serostatus, and underlying comorbidities on humoral response post-SARS-CoV-2 Pfizer-BioNTech mRNA vaccination: a systematic review
Kin Israel Notarte, Abbygail Therese Ver, Jacqueline Veronica Velasco, et al.
Critical Reviews in Clinical Laboratory Sciences (2022) Vol. 59, Iss. 6, pp. 373-390
Open Access | Times Cited: 88
Immunogenicity and Risk Factors Associated With Poor Humoral Immune Response of SARS-CoV-2 Vaccines in Recipients of Solid Organ Transplant
Kasama Manothummetha, Nipat Chuleerarux, Anawin Sanguankeo, et al.
JAMA Network Open (2022) Vol. 5, Iss. 4, pp. e226822-e226822
Open Access | Times Cited: 87
B and T Cell Responses after a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients
Eva Schrezenmeier, Héctor Rincón-Arévalo, Ana‐Luisa Stefanski, et al.
Journal of the American Society of Nephrology (2021) Vol. 32, Iss. 12, pp. 3027-3033
Open Access | Times Cited: 86
Efficacy of COVID-19 vaccines in immunocompromised patients: A systematic review and meta-analysis
Ainsley Ryan Yan Bin Lee, Shi Yin Wong, Louis Yi Ann Chai, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 83
A prospective observational study for justification, safety, and efficacy of a third dose of mRNA vaccine in patients receiving maintenance hemodialysis
Maxime Espi, Xavier Charmetant, Thomas Barba, et al.
Kidney International (2021) Vol. 101, Iss. 2, pp. 390-402
Open Access | Times Cited: 77
Immunogenicity Rates After SARS-CoV-2 Vaccination in People With End-stage Kidney Disease
Jia‐Jin Chen, Tao Han Lee, Ya‐Chung Tian, et al.
JAMA Network Open (2021) Vol. 4, Iss. 10, pp. e2131749-e2131749
Open Access | Times Cited: 63
Humoral response to a third injection of BNT162b2 vaccine in patients on maintenance haemodialysis
Marine Dekervel, Nicolás Henry, Massimo Torreggiani, et al.
Clinical Kidney Journal (2021) Vol. 14, Iss. 11, pp. 2349-2355
Open Access | Times Cited: 58
Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: A systematic literature review and meta-analysis
Alexandre R. Marra, Takaaki Kobayashi, Hiroyuki Suzuki, et al.
Journal of Infection (2022) Vol. 84, Iss. 3, pp. 297-310
Open Access | Times Cited: 56
Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months
Caroline M. Hsu, Daniel E. Weiner, Harold J. Manley, et al.
Clinical Journal of the American Society of Nephrology (2022) Vol. 17, Iss. 3, pp. 403-413
Open Access | Times Cited: 53
Immunogenicity of COVID-19 vaccines in solid organ transplant recipients: a systematic review and meta-analysis
Xinpei Chen, De Luo, Bingjie Mei, et al.
Clinical Microbiology and Infection (2022) Vol. 29, Iss. 4, pp. 441-456
Open Access | Times Cited: 44
A CRISPR-based ultrasensitive assay detects attomolar concentrations of SARS-CoV-2 antibodies in clinical samples
Yanan Tang, Turun Song, Lu Gao, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 38
Longitudinal analysis of anti-SARS-CoV-2 S-RBD IgG antibodies before and after the third dose of the BNT162b2 vaccine
Bruna Lo Sasso, Luisa Agnello, Rosaria Vincenza Giglio, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 37
Humoral Response in Hemodialysis Patients Post-SARS-CoV-2 mRNA Vaccination: A Systematic Review of Literature
Kin Israel Notarte, Jesus Alfonso Catahay, Princess Juneire Peligro, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 724-724
Open Access | Times Cited: 28
Antibody Responses after a Third Dose of COVID-19 Vaccine in Kidney Transplant Recipients and Patients Treated for Chronic Lymphocytic Leukemia
Julien Marlet, Philippe Gatault, Zoha Maakaroun, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1055-1055
Open Access | Times Cited: 43
mRNA COVID-19 vaccine booster fosters B- and T-cell responses in immunocompromised patients
Elena Azzolini, Chiara Pozzi, Luca Germagnoli, et al.
Life Science Alliance (2022) Vol. 5, Iss. 6, pp. e202201381-e202201381
Open Access | Times Cited: 33
Recent developments in SARS‐CoV‐2 vaccines: A systematic review of the current studies
Mona Sadeghalvad, Amir Hossein Mansourabadi, Maryam Noori, et al.
Reviews in Medical Virology (2022) Vol. 33, Iss. 1
Open Access | Times Cited: 31
Humoral and cellular response of COVID‐19 vaccine among solid organ transplant recipients: A systematic review and meta‐analysis
Hari Shankar Meshram, Vivek Kute, Hemant Rane, et al.
Transplant Infectious Disease (2022) Vol. 24, Iss. 6
Open Access | Times Cited: 30
Immunogenicity and Safety of COVID-19 Vaccines in Patients Receiving Renal Replacement Therapy: A Systematic Review and Meta-Analysis
Becky Mingyao, Anthony Raymond Tam, Kam Wa Chan, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 29
Perspective on COVID-19 vaccination in patients with immune-mediated kidney diseases: consensus statements from the ERA-IWG and EUVAS
Kate Stevens, Eleni Frangou, Jae Il Shin, et al.
Nephrology Dialysis Transplantation (2022) Vol. 37, Iss. 8, pp. 1400-1410
Open Access | Times Cited: 28
Impact of immunosuppressive regimens on antibody response after COVID-19 vaccination among Thai kidney transplant recipients
Nuttasith Larpparisuth, Kritsada Pongsakornkullachart, Nartsiri Ratchawang, et al.
Heliyon (2025) Vol. 11, Iss. 3, pp. e42291-e42291
Open Access
Diminished and waning immunity to COVID-19 vaccination among hemodialysis patients in Israel: the case for a third vaccine dose
Avital Angel-Korman, Esther Peres, Gabriel Bryk, et al.
Clinical Kidney Journal (2021) Vol. 15, Iss. 2, pp. 226-234
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top